U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Drug Supply Chain Integrity
  5. Drug Supply Chain Security Act (DSCSA)
  6. DSCSA Pilot Project Program
  1. Drug Supply Chain Security Act (DSCSA)

DSCSA Pilot Project Program

FDA’s Drug Supply Chain Security Act (DSCSA) Pilot Project Program has concluded, and the final program report is available so that all supply chain stakeholders can benefit from the information gathered and lessons learned. FDA considered all viable technologies and methods from the pilot projects that would support enhanced product tracing and verification. This program was an opportunity to test technologies or methods for enhanced drug distribution security requirements outlined in the law.

This program was established to assist drug supply chain stakeholders, including FDA, with developing electronic, interoperable capabilities that will identify and trace certain prescription drugs as they are distributed within the U.S. FDA worked with the selected participants to explore and evaluate methods to enhance the safety and security of the drug supply chain. Participants reflected the diversity of the supply chain, including large and small entities from all industry sectors.

The program was established to assist members of the drug supply chain with developing capabilities to identify and trace certain prescription drugs as they are distributed within the U.S.

The program goals were to:

  • identify the system attributes needed to implement the requirements of section 582 of the FD&C Act, particularly the requirement to utilize a product identifier for product tracing and verification purposes and
  • assess the ability of supply chain members to satisfy the requirements of section 582 of the FD&C Act; identify, manage and prevent the distribution of suspect and illegitimate products as defined in section 581(21) and 581(8) of the FD&C Act, respectively; and exchange product tracing information across the pharmaceutical distribution supply chain in an electronic and interoperable manner.

Selection into this program should not be interpreted as FDA’s position on an entity’s compliance with regulatory requirements or an endorsement of a particular technology, system or other approach used in the pilots.

FDA is bound by federal law and regulations to keep commercial confidential and trade secret information from public disclosure across all programs. Any such information that was submitted to us in the program has not been disclosed publicly, including confidential sales information, customer and supplier names, contractor and consultant names and business plans. All information in the individual pilot project links below has been freely provided by the program participants.

Contact the project lead with questions about a pilot project.

Pilot Project Participants

Project Leads

Pilot Project Title


AmerisourceBergen/Xavier Health

AmerisourceBergen Xavier Health End-to-End 2023 Proof of Concept Pilot

Matthew Sample:

Cardinal Health

Interoperability Data Exchange Errors and Exception Handling

Maryann Nelson:

Franciscan Missionaries of Our Lady Health System (FMOLHS)

DSCSA Verification to Improve Product Traceability at FMOL Health System

Chris Chandler:


Barcode Readability for DSCSA 2023 Interoperability

Tracy Nasarenko:


DSCSA Blockchain Interoperability Pilot (PDF - 1 MB)

Gloria Candelario Hossri gloria.candelario.hossri@merck.com


Web 3.0 based on Identifier system:

An autonomous system for electronic tracing of product for pharmaceutical

Anurag Saxena:


IDLogiq Next Generation Advanced REAL FIPS-Compliant Cryptographic ID Authentication with Transaction Ledger Powered by Blockchain/Distributed Ledger Technology for Decentralized Heterogeneous Global Network Computing Environment

Kelly Nguyen:

Kit Check and Sandoz

Analyzing gaps and addressing key concerns and testing key concepts relating to the 2023 DSCSA requirements by utilizing and adapting existing commercial methods and technologies

Ramsey Doany:


Router Service Solution for Verification/Notification and Interoperability 2023

Riya Cao:


MediLedger DSCSA Pilot

Eric Garvin:


Improved end-to-end drug supply chain traceability with OPTEL’s Intelligent Supply ChainTM technologies

Simon Bastarache:

The Optimal Solution

The Optimal Solution a Federated Approach to Designing the Interoperable DSCSA

Dwight de Vera:

Pharmaceutical Distribution Security Alliance (PDSA)

DSCSA Governance Processes

Eric Marshall:

PriMed Pharmaceuticals

Secondary Wholesaler Challenges During Implementation of DSCSA Required Track & Trace Platforms

Jennifer Ruggiero:

Providence Health Technologies (PHT)

FDA Small Dispenser Pilot Study

Todd Barrett:


rfxcel Verification/Notification Readiness & Extensibility Pilot

Herb Wong:


DSCSA Implementation in Intra and Inter Healthcare System Medicine Transfers

Jason Cross:


Product Identifier Verifications by a Contract Manufacturing Organization on behalf of a Manufacturer Authorization Holder

Arthi Nagaraj:


DSCSA Traceability with Distributed Ledgers and Digital Recalls Project Proposal

Brian Daleiden:

UCLA Health

UCLA-LedgerDomain: DSCSA Solution Through Blockchain Technology

Ben Taylor:

Back to Top